Cargando…

Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma

Background: Angiogenesis inhibitors have become an important therapeutic approach in the treatment of hepatocellular carcinoma (HCC) patients. The therapeutic inhibition of angiogenesis of Sorafenib in increasing overall survival of patients with HCC is a fundamental element of the treatment of this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berretta, Massimiliano, Rinaldi, Luca, Di Benedetto, Fabrizio, Lleshi, Arben, De Re, Vallì, Facchini, Gaetano, De Paoli, Paolo, Di Francia, Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101236/ https://www.ncbi.nlm.nih.gov/pubmed/27881963 http://dx.doi.org/10.3389/fphar.2016.00428

Ejemplares similares

Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the Literature
por: Tarantino, Giuseppe, et al.
Publicado: (2016)

Pharmacogenetic-Based Interactions between Nutraceuticals and Angiogenesis Inhibitors
por: Di Francia, Raffaele, et al.
Publicado: (2019)

Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results
por: Di Francia, Raffaele, et al.
Publicado: (2017)

Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies
por: Berretta, Massimiliano, et al.
Publicado: (2018)

Drug–Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection
por: Berretta, Massimiliano, et al.
Publicado: (2016)

Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey
por: Berretta, Massimiliano, et al.
Publicado: (2016)

Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study
por: Berretta, Massimiliano, et al.
Publicado: (2020)

Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies
por: Berretta, Massimiliano, et al.
Publicado: (2020)

Glutathione: Lights and Shadows in Cancer Patients
por: Marini, Herbert Ryan, et al.
Publicado: (2023)

Resveratrol in Cancer Patients: From Bench to Bedside
por: Berretta, Massimiliano, et al.
Publicado: (2020)

Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale”
por: Cecere, Sabrina C., et al.
Publicado: (2016)

Corrigendum: Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale”
por: Cecere, Sabrina C., et al.
Publicado: (2016)

From Clinical Trials to the Front Line: Vinflunine for Treatment of Urothelial Cell Carcinoma at the National Cancer Institute of Naples
por: Facchini, Gaetano, et al.
Publicado: (2016)

A new peg-filgrastim biosimilar, mecapegfilgrastim for primary prophylaxis of chemotherapy-related neutropenia is now available
por: Tirelli, Umberto, et al.
Publicado: (2020)

Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications
por: Berretta, Massimiliano, et al.
Publicado: (2016)

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma
por: Rossetti, Sabrina, et al.
Publicado: (2017)

Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival
por: Facchini, Gaetano, et al.
Publicado: (2016)

The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies
por: Berretta, Massimiliano, et al.
Publicado: (2022)

Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up
por: Sardu, Celestino, et al.
Publicado: (2021)

The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma
por: Montella, Liliana, et al.
Publicado: (2021)

Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian “Real-World” SAX Study
por: D'Aniello, Carmine, et al.
Publicado: (2016)

Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity
por: Berretta, Massimiliano, et al.
Publicado: (2022)

Extract of Marsdenia tenacissima (Roxb.) Moon [Apocynaceae] Suppresses Hepatocellular Carcinoma by Inhibiting Angiogenesis
por: Pan, Yating, et al.
Publicado: (2022)

Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress
por: Cocetta, Veronica, et al.
Publicado: (2021)

A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma?
por: Montella, Liliana, et al.
Publicado: (2021)

Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models
por: Clemente, Nausicaa, et al.
Publicado: (2019)

Dandelion Polysaccharide Exerts Anti-Angiogenesis Effect on Hepatocellular Carcinoma by Regulating VEGF/HIF-1α Expression
por: Ren, Feng, et al.
Publicado: (2020)

Sonoporation by microbubbles as gene therapy approach against liver cancer
por: Rinaldi, Luca, et al.
Publicado: (2018)

Correction: Sonoporation by microbubbles as gene therapy approach against liver cancer
por: Rinaldi, Luca, et al.
Publicado: (2018)

Circulating Vitamin D Level and Its Impact on Mortality and Recurrence in Stage III Colorectal Cancer Patients: A Systematic Review and Meta-Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas
por: Crisci, Stefania, et al.
Publicado: (2019)

Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the Literature
por: Berretta, M., et al.
Publicado: (2022)

Angiogenesis Inhibitors in NSCLC
por: Manzo, Anna, et al.
Publicado: (2017)

Target Therapies in Lung Cancer
por: Bearz, A., et al.
Publicado: (2011)

Editorial: Angiogenesis and Nutraceuticals
por: Trabalzini, Lorenza, et al.
Publicado: (2022)

Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis
por: Di Franco, Rossella, et al.
Publicado: (2017)

Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
por: Repetto, Ombretta, et al.
Publicado: (2014)

A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression
por: Zhou, Zijun, et al.
Publicado: (2020)

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
por: Jiang, Lei, et al.
Publicado: (2023)

Biphasic Effect of Pirfenidone on Angiogenesis
por: Gan, Donghao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iqvgsumv9b9r9tmh1945iablin